The infant of a mother with hydraminos must be assessed with esophageal atresia.
Hydraminos is excessive amniotic fluid. Any child born to a woman with hydramnios must have esophageal atresia ruled out. Because a fetus typically swallows amniotic fluid during intrauterine life, hydramnios happens. As a result of the fetus's inability to swallow properly due to esophageal atresia, the amniotic fluid level may become unusually high.
<h3>
What is esophageal atresia?</h3>
When a newborn is born with esophageal atresia (EA), a portion of the esophagus is absent (the tube that connects the mouth to the stomach). The esophagus develops as two distinct, unconnected segments rather than as a tube connecting the mouth and the stomach. Some children have esophageal defects that prevent the ends from being surgically joined. Long-gap EA is what this is called.
To learn more about esophageal atresia with the help of given link:
brainly.com/question/13125577
#SPJ4
Answer:
<em>The ability of a specific tissue or organ to respond to the presence of a hormone is dependent on the presence of the appropriate receptors on the cells of the target tissue or organ- C.</em>
Answer:
According to the American Academy of Pediatrics (AAP), a baby should consume, on average, about 2.5 ounces of formula a day for every pound of their body weight. For example, a 12-pound baby would likely need 30 ounces in a 24-hour period.
According to a study, venetoclax plus hypomethylating agent is effective in newly diagnosed acute myeloid leukemia, and safe in an outpatient setting. So the statement is true.
<h3>What is venetoclax?</h3>
Venetoclax is either used alone or in combination with another drug called obinutuzumab or rituximab. This is used for the treatment of certain types of chronic lymphocytic leukemia. It is a type of cancer that develops in white blood cells. It is also used for certain types of small lymphocytic lymphoma, which is a type of cancer that develops in the lymph nodes.
It can also be used in combination with either azacitidine, decitabine, or cytarabine. This is done as the initial treatment for acute myeloid leukemia, which is a type of cancer that begins in the white blood cells in people who are 75 years or older. It can also develop in adults having medical conditions that prevent them from being treated with any other treatment than chemotherapy medications.
The class of medications from which Venetoclax belongs is called B-cell lymphoma-2 inhibitors. These medicines work by blocking the action of a particular protein in the body that promotes cancer cells' survival. This helps in killing cancer cells.
Therefore, the statement is true.
Read more about leukemia, here
brainly.com/question/5868856
#SPJ4
Answer:
Compare your info
Explanation:
Read everything carefully and compare your info and data to find the best solution.
